J8501 Oral aprepitantAprepitant, oral, 5 mg
J8501 payment limit: $2.511 per 5 MG, effective October 1, 2026 through December 31, 2026, based on 2Q26 ASP data. Coinsurance 20%.
68001-0666-01 Aprepitant, BluePoint Laboratories: 8 billing units per package (1 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)68001-0666-17 Aprepitant, BluePoint Laboratories: 40 billing units per package (5 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)68001-0667-01 Aprepitant, BluePoint Laboratories: 32 billing units per package (2 CAPSULE in 1 DOSE PACK)68001-0667-19 Aprepitant, BluePoint Laboratories: 96 billing units per package (1 BLISTER PACK in 1 CARTON / 6 CAPSULE in 1 BLISTER PACK)68001-0668-19 Aprepitant, BluePoint Laboratories: 150 billing units per package (1 BLISTER PACK in 1 CARTON / 6 CAPSULE in 1 BLISTER PACK)68001-0669-15 Aprepitant, BluePoint Laboratories: 57 billing units per package (1 KIT in 1 DOSE PACK * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK)68462-0112-33 Aprepitant, Glenmark Pharmaceuticals Inc., USA: 57 billing units per package (1 KIT in 1 DOSE PACK * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK)68462-0583-40 Aprepitant, Glenmark Pharmaceuticals Inc., USA: 8 billing units per package (1 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)68462-0583-85 Aprepitant, Glenmark Pharmaceuticals Inc., USA: 40 billing units per package (5 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)68462-0584-58 Aprepitant, Glenmark Pharmaceuticals Inc., USA: 32 billing units per package (2 CAPSULE in 1 DOSE PACK)68462-0584-76 Aprepitant, Glenmark Pharmaceuticals Inc., USA: 96 billing units per package (1 BLISTER PACK in 1 CARTON / 6 CAPSULE in 1 BLISTER PACK)68462-0585-76 Aprepitant, Glenmark Pharmaceuticals Inc., USA: 150 billing units per package (1 BLISTER PACK in 1 CARTON / 6 CAPSULE in 1 BLISTER PACK)00781-2321-06 Aprepitant, Sandoz Inc.: 8 billing units per package (1 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)00781-2321-51 Aprepitant, Sandoz Inc.: 40 billing units per package (5 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)00781-2322-46 Aprepitant, Sandoz Inc.: 32 billing units per package (2 CAPSULE in 1 DOSE PACK)00781-2322-68 Aprepitant, Sandoz Inc.: 96 billing units per package (1 BLISTER PACK in 1 CARTON / 6 CAPSULE in 1 BLISTER PACK)00781-2323-68 Aprepitant, Sandoz Inc.: 150 billing units per package (1 BLISTER PACK in 1 CARTON / 6 CAPSULE in 1 BLISTER PACK)00781-4063-36 Aprepitant, Sandoz Inc.: 57 billing units per package (1 KIT in 1 DOSE PACK * 1 CAPSULE in 1 BLISTER PACK * 2 CAPSULE in 1 BLISTER PACK)13668-0591-81 Aprepitant, Torrent Pharmaceuticals Limited: 8 billing units per package (1 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)13668-0591-82 Aprepitant, Torrent Pharmaceuticals Limited: 40 billing units per package (5 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)13668-0592-84 Aprepitant, Torrent Pharmaceuticals Limited: 32 billing units per package (2 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)13668-0592-86 Aprepitant, Torrent Pharmaceuticals Limited: 96 billing units per package (3 BLISTER PACK in 1 CARTON / 2 CAPSULE in 1 BLISTER PACK)13668-0593-86 Aprepitant, Torrent Pharmaceuticals Limited: 150 billing units per package (6 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK)13668-0594-87 Aprepitant, Torrent Pharmaceuticals Limited: 57 billing units per package (1 KIT in 1 DOSE PACK * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK)00006-0461-02 Emend, Merck Sharp & Dohme LLC: 32 billing units per package (2 CAPSULE in 1 DOSE PACK)00006-3066-03 Emend, Merck Sharp & Dohme LLC: 25 billing units per package (1 POUCH in 1 CARTON / 1 POWDER, FOR SUSPENSION in 1 POUCH)00006-3862-03 Emend, Merck Sharp & Dohme LLC: 57 billing units per package (1 KIT in 1 DOSE PACK * 1 CAPSULE in 1 CAPSULE * 1 CAPSULE in 1 CAPSULE)Status E: excluded from the PFS by regulation.
J8501 appears in 4 coverage policies from Aetna, Centene, UnitedHealthcare.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Revakinagene Taroretcel-lwey (Encelto) (1079) | listed, no stance (range J8501-J9999) | Oct 5, 2026 | payer document |
| Centene | Aprepitant (Aponvie, Emend, Cinvanti), Fosaprepitant (Emend for Injection, Focinvez) (CP.PMN.19) | covered if criteria are met | Aug 1, 2026 | payer document |
| UnitedHealthcare | Antiemetics for Oncology (CS2026D0093O) | listed, no stance | Apr 1, 2026 | payer document |
| UnitedHealthcare | Oncology Medication Clinical Coverage (2026D0030AR) | listed, no stance | Sep 1, 2026 | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.